NasdaqCM - Delayed Quote USD

AdaptHealth Corp. (AHCO)

9.96 +0.38 (+3.97%)
At close: April 26 at 4:00 PM EDT
9.96 0.00 (0.00%)
After hours: April 26 at 4:20 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
3,200,177.00
3,200,177.00
2,970,595.00
2,454,535.00
1,056,389.00
Cost of Revenue
2,720,613.00
2,720,613.00
2,553,169.00
2,008,925.00
898,601.00
Gross Profit
479,564.00
479,564.00
417,426.00
445,610.00
157,788.00
Operating Expense
247,178.00
247,178.00
227,015.00
220,005.00
86,442.00
Operating Income
232,386.00
232,386.00
190,411.00
225,605.00
71,346.00
Net Non Operating Interest Income Expense
-130,299.00
-130,299.00
-109,414.00
-95,195.00
-41,430.00
Other Income Expense
-825,871.00
-825,871.00
16,905.00
60,549.00
-235,957.00
Pretax Income
-723,784.00
-723,784.00
97,902.00
190,959.00
-206,041.00
Tax Provision
-49,004.00
-49,004.00
24,769.00
32,806.00
-11,955.00
Net Income Common Stockholders
-678,895.00
-678,895.00
63,449.00
141,796.00
-161,632.00
Average Dilution Earnings
-34,482.00
-34,482.00
-17,158.00
-53,181.00
--
Diluted NI Available to Com Stockholders
-713,377.00
-713,377.00
46,291.00
88,615.00
-161,632.00
Basic EPS
-5.06
-5.06
0.47
1.12
-3.08
Diluted EPS
-5.31
-5.31
0.33
0.67
-3.08
Basic Average Shares
134,156.00
134,156.00
134,175.00
126,306.00
52,488.00
Diluted Average Shares
134,418.00
134,418.00
138,988.00
133,034.00
52,488.00
Total Operating Income as Reported
-598,401.00
-598,401.00
190,411.00
225,605.00
71,346.00
Rent Expense Supplemental
67,783.00
67,783.00
64,375.00
48,586.00
22,344.00
Total Expenses
2,967,791.00
2,967,791.00
2,780,184.00
2,228,930.00
985,043.00
Net Income from Continuing & Discontinued Operation
-678,895.00
-678,895.00
69,316.00
156,175.00
-161,632.00
Normalized Income
63,495.95
63,495.95
56,498.94
104,523.53
63,883.74
Interest Expense
130,299.00
130,299.00
109,414.00
95,195.00
41,430.00
Net Interest Income
-130,299.00
-130,299.00
-109,414.00
-95,195.00
-41,430.00
EBIT
-593,485.00
-593,485.00
207,316.00
286,154.00
-164,611.00
EBITDA
-210,702.00
-210,702.00
558,494.00
544,207.00
-82,166.00
Reconciled Cost of Revenue
2,394,917.00
2,394,917.00
2,266,881.00
1,813,967.00
827,529.00
Reconciled Depreciation
382,783.00
382,783.00
351,178.00
258,053.00
82,445.00
Net Income from Continuing Operation Net Minority Interest
-678,895.00
-678,895.00
69,316.00
156,175.00
-161,632.00
Total Unusual Items Excluding Goodwill
-796,305.00
-796,305.00
17,158.00
62,381.00
-239,401.00
Total Unusual Items
-796,305.00
-796,305.00
17,158.00
62,381.00
-239,401.00
Normalized EBITDA
585,603.00
585,603.00
541,336.00
481,826.00
157,235.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-53,914.05
-53,914.05
4,340.94
10,729.53
-13,885.26
12/31/2020 - 5/31/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ATEC Alphatec Holdings, Inc.
12.44
+1.63%
 
QIPT Quipt Home Medical Corp.
3.6600
0.00%
 
NURO NeuroMetrix, Inc.
4.4400
+0.68%
 
LIVN LivaNova PLC
55.53
+0.78%
 
UFPT UFP Technologies, Inc.
213.25
+1.72%
 
INGN Inogen, Inc.
6.78
+4.63%
 
VMD Viemed Healthcare, Inc.
8.31
+3.75%
 
AORT Artivion, Inc.
20.57
+1.48%
 
RXST RxSight, Inc.
52.77
+1.70%
 
CNMD CONMED Corporation
65.78
+6.27%